BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27797985)

  • 1. Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial.
    Violato M; Dakin H; Chakravarthy U; Reeves BC; Peto T; Hogg RE; Harding SP; Scott LJ; Taylor J; Cappel-Porter H; Mills N; O'Reilly D; Rogers CA; Wordsworth S
    BMJ Open; 2016 Oct; 6(10):e011121. PubMed ID: 27797985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial.
    Reeves BC; Scott LJ; Taylor J; Hogg R; Rogers CA; Wordsworth S; Townsend D; Muldrew A; Peto T; Violato M; Dakin H; Cappel-Porter H; Mills N; O'Reilly D; Harding SP; Chakravarthy U
    Health Technol Assess; 2016 Oct; 20(80):1-120. PubMed ID: 27809956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.
    Reeves BC; Scott LJ; Taylor J; Harding SP; Peto T; Muldrew A; Hogg RE; Wordsworth S; Mills N; O'Reilly D; Rogers CA; Chakravarthy U
    BMJ Open; 2016 Jul; 6(7):e010685. PubMed ID: 27401357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease.
    Taylor J; Scott LJ; Rogers CA; Muldrew A; O'Reilly D; Wordsworth S; Mills N; Hogg R; Violato M; Harding SP; Peto T; Townsend D; Chakravarthy U; Reeves BC
    Eye (Lond); 2016 Jan; 30(1):68-78. PubMed ID: 26449197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment decisions of UK hospital optometrists and ophthalmologists in patients with nAMD: a vignette study.
    Creer RC; Roberts SA; Aslam TM; Balaskas K; Chhabra R; Mahmood S; Turner GS; Harper RA
    Ophthalmic Physiol Opt; 2019 Nov; 39(6):432-440. PubMed ID: 31602674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health professionals' and service users' perspectives of shared care for monitoring wet age-related macular degeneration: a qualitative study alongside the ECHoES trial.
    Townsend D; Reeves BC; Taylor J; Chakravarthy U; O'Reilly D; Hogg RE; Mills N
    BMJ Open; 2015 Apr; 5(4):e007400. PubMed ID: 25900465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of training, patient and practitioner perspectives on community-based monitoring of patients with stable age-related macular degeneration compared to hospital-based care: The FENETRE study report no. 1.
    Read S; Lawrenson JG; Harper RA; Hanley T; Balaskas K; Waterman H
    Ophthalmic Physiol Opt; 2021 Jul; 41(4):864-873. PubMed ID: 34036613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared care for chronic eye diseases: perspectives of ophthalmologists, optometrists and patients.
    O'Connor PM; Harper CA; Brunton CL; Clews SJ; Haymes SA; Keeffe JE
    Med J Aust; 2012 Jun; 196(10):646-50. PubMed ID: 22676881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.
    Lois N; Cook J; Wang A; Aldington S; Mistry H; Maredza M; McAuley D; Aslam T; Bailey C; Chong V; Ghanchi F; Scanlon P; Sivaprasad S; Steel D; Styles C; Azuara-Blanco A; Prior L; Waugh N
    Health Technol Assess; 2021 May; 25(32):1-104. PubMed ID: 34060440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing costs of monitoring glaucoma patients: hospital ophthalmologists versus community optometrists.
    Coast J; Spencer IC; Smith L; Spry PG
    J Health Serv Res Policy; 1997 Jan; 2(1):19-25. PubMed ID: 10180649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN).
    Chakravarthy U; Harding SP; Rogers CA; Downes S; Lotery AJ; Dakin HA; Culliford L; Scott LJ; Nash RL; Taylor J; Muldrew A; Sahni J; Wordsworth S; Raftery J; Peto T; Reeves BC
    Health Technol Assess; 2015 Oct; 19(78):1-298. PubMed ID: 26445075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian optometric and ophthalmologic referral pathways for people with age-related macular degeneration, diabetic retinopathy and glaucoma.
    Jamous KF; Jalbert I; Kalloniatis M; Boon MY
    Clin Exp Optom; 2014 May; 97(3):248-55. PubMed ID: 24400653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the efficacy of an online tool for improving the diagnosis of macular lesions imaged by optical coherence tomography.
    Grace P; Evans BJW; Edgar DF; Patel PJ; Thomas D; Mahon G; Blake A; Bennett D
    J Optom; 2021; 14(2):206-214. PubMed ID: 33132077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-stakeholder perspectives of locally commissioned enhanced optometric services.
    Baker H; Harper RA; Edgar DF; Lawrenson JG
    BMJ Open; 2016 Oct; 6(10):e011934. PubMed ID: 27798000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agreement in clinical decision-making between independent prescribing optometrists and consultant ophthalmologists in an emergency eye department.
    Todd D; Bartlett H; Thampy R; Dhawahir-Scala F; Wilson H; Tromans C
    Eye (Lond); 2020 Dec; 34(12):2284-2294. PubMed ID: 32203243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation.
    Mowatt G; Hernández R; Castillo M; Lois N; Elders A; Fraser C; Aremu O; Amoaku W; Burr J; Lotery A; Ramsay C; Azuara-Blanco A
    Health Technol Assess; 2014 Dec; 18(69):1-254. PubMed ID: 25436855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported optometric practise patterns in age-related macular degeneration.
    Ly A; Nivison-Smith L; Zangerl B; Assaad N; Kalloniatis M
    Clin Exp Optom; 2017 Nov; 100(6):718-728. PubMed ID: 28266060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical audit as an educative tool for optometrists: an intervention study in age-related macular degeneration.
    Gocuk SA; Lee JH; Keller PR; Ayton LN; Guymer RH; McKendrick AM; Downie LE
    Ophthalmic Physiol Opt; 2021 Jan; 41(1):53-72. PubMed ID: 33156555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agreement between ophthalmologists and optometrists in the certification of vision impairment.
    Bartlett R; Jones H; Williams G; Farewell D; Acton JH
    Eye (Lond); 2021 Feb; 35(2):433-440. PubMed ID: 32317794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workforce supply of eye care providers in Canada: optometrists, ophthalmologists, and subspecialty ophthalmologists.
    Al Ali A; Hallingham S; Buys YM
    Can J Ophthalmol; 2015 Dec; 50(6):422-8. PubMed ID: 26651300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.